CLMT Stock - Calumet, Inc.
Unlock GoAI Insights for CLMT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.19B | $4.18B | $4.69B | $3.15B | $2.27B |
| Gross Profit | $230.80M | $451.70M | $351.70M | $142.90M | $99.10M |
| Gross Margin | 5.5% | 10.8% | 7.5% | 4.5% | 4.4% |
| Operating Income | $8.10M | $267.20M | $131.90M | $-85,600,000 | $-71,900,000 |
| Net Income | $-222,000,000 | $48.10M | $-173,300,000 | $-254,900,000 | $-149,000,000 |
| Net Margin | -5.3% | 1.2% | -3.7% | -8.1% | -6.6% |
| EPS | $-2.67 | $0.59 | $-2.14 | $-3.23 | $-1.86 |
Calumet, Inc. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 11th 2025 | TD Cowen | Reiterated | Hold | $18← $15 |
| May 13th 2025 | BofA Securities | Initiation | Buy | $15 |
| March 17th 2025 | UBS | Upgrade | Neutral | $12← $15 |
| March 4th 2025 | TD Cowen | Downgrade | Hold | $16← $26 |
| February 4th 2025 | UBS | Downgrade | Sell | $15← $20.5 |
| November 11th 2024 | TD Cowen | Reiterated | Buy | $26← $27 |
| October 17th 2024 | TD Cowen | Reiterated | Buy | $27← $22 |
| August 12th 2024 | TD Cowen | Reiterated | Buy | $18← $20 |
| August 18th 2022 | Goldman | Upgrade | Buy | $23← $14 |
Earnings History & Surprises
CLMTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q1 2026 | Feb 27, 2026 | $-0.64 | — | — | — |
Q4 2025 | Nov 7, 2025 | $-0.30 | $-0.21 | +30.0% | ✓ BEAT |
Q3 2025 | Aug 8, 2025 | $-0.44 | $-1.70 | -286.4% | ✗ MISS |
Q2 2025 | May 9, 2025 | $-0.41 | $-1.03 | -151.2% | ✗ MISS |
Q1 2025 | Feb 28, 2025 | $-1.06 | $-0.47 | +55.7% | ✓ BEAT |
Q4 2024 | Nov 8, 2024 | $-0.59 | $-0.81 | -37.3% | ✗ MISS |
Q3 2024 | Aug 9, 2024 | $-0.70 | $-0.48 | +31.4% | ✓ BEAT |
Q2 2024 | May 10, 2024 | $-0.74 | $-0.61 | +17.6% | ✓ BEAT |
Q1 2024 | Feb 23, 2024 | $-0.44 | $-0.79 | -79.5% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.13 | $0.03 | +123.1% | ✓ BEAT |
Q3 2023 | Aug 4, 2023 | $-0.07 | $-0.19 | -171.4% | ✗ MISS |
Q2 2023 | May 5, 2023 | $0.02 | $0.10 | +390.0% | ✓ BEAT |
Q1 2023 | Mar 15, 2023 | $-0.00 | $-0.21 | -524900.0% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $0.46 | $0.59 | +28.3% | ✓ BEAT |
Q3 2022 | Aug 5, 2022 | $0.25 | $0.48 | +92.0% | ✓ BEAT |
Q2 2022 | May 6, 2022 | $-0.56 | $-0.87 | -55.4% | ✗ MISS |
Q1 2022 | Feb 25, 2022 | $-0.35 | $-1.08 | -208.6% | ✗ MISS |
Q4 2021 | Nov 5, 2021 | $-0.15 | $0.64 | +526.7% | ✓ BEAT |
Q3 2021 | Aug 6, 2021 | $-0.58 | $-0.97 | -67.2% | ✗ MISS |
Latest News
HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $33 Price Target
📈 PositiveCalumet Specialty Prods Q3 EPS $3.61 May Not Compare To $(0.38) Estimate, Sales $1.078B Beat $1.052B Estimate
📈 PositiveGoldman Sachs Maintains Buy on Calumet, Raises Price Target to $20
📈 PositiveCalumet Wins EPA Approval For Small Refinery Exemptions, Slashes RIN Liability By Over 75%
📈 PositiveFrequently Asked Questions about CLMT
What is CLMT's current stock price?
What is the analyst price target for CLMT?
What sector is Calumet, Inc. in?
What is CLMT's market cap?
Does CLMT pay dividends?
Similar Stocks
Energy SectorExplore stocks similar to CLMT for comparison